MARKET

GSK

GSK

GSK
NYSE

Real-time Quotes | Nasdaq Last Sale

38.39
-0.95
-2.41%
After Hours: 38.35 -0.04 -0.10% 19:08 09/24 EDT
OPEN
38.54
PREV CLOSE
39.34
HIGH
38.70
LOW
38.37
VOLUME
4.36M
TURNOVER
--
52 WEEK HIGH
42.68
52 WEEK LOW
33.26
MARKET CAP
96.58B
P/E (TTM)
16.03
1D
5D
1M
3M
1Y
5Y
Antiretroviral Drugs Market: Industry Insights By Growth, Emerging Trends And Forecast By 2028
Research Nester has published a report titled "which delivers detailed overview of the antiretroviral drugs market in terms of market segmentation by drug type and by region.
AmericaNewsHour · 1d ago
DeSantis Says Florida Acquired Glaxosmithkline Monoclonals
Bloomberg · 1d ago
Activist Bluebell Raises Pressure on Glaxo CEO Walmsley
(Bloomberg) -- Activist hedge fund Bluebell Capital Partners turned up the pressure on GlaxoSmithKline Plc Chief Executive Officer Emma Walmsley, questioning her leadership of the U.K. drugmaker after following Elliott Investment Management in buying a sta...
Bloomberg · 2d ago
U.S. to Clear Third Pfizer Dose; Singapore Cases: Virus Update
(Bloomberg) -- U.S. regulators are set to authorize a third dose of Pfizer Inc.’s vaccine for people 65 and over. Anthony Fauci said he expects mRNA vaccines to be administered as a three-dose regimen. Most Read from BloombergThe Global Housing Market Is B...
Bloomberg · 2d ago
Activist Bluebell Takes Aim at Glaxo CEO After Elliott Stake
Bloomberg · 2d ago
Activist investor Bluebell takes stake in GSK
Bluebell said in a letter to GSK Chairman Jonathan Symonds that chief executive Emma Walmsley should reapply for her job as she would have “renewed credibility both internally and externally”, the FT report said. Earlier this year, activist Elliott had al...
Reuters · 2d ago
Activist investor Bluebell takes stake in GSK - FT
Activist investor Bluebell Capital Partners has taken a small stake in British pharmaceuticals group GlaxoSmithKline in efforts to shake up top management, a Financial Times report https://www.ft.com/content/539c077d-6ac2-4e79-9e0f-8080a31c5530 said on Wed...
Reuters · 2d ago
GlaxoSmithKline Spokesperson Says Bluebell Capital Partners Has Sent Letter To Chairman; Says Points Set Out In Letter Are Not New, Says Has Already Made Clear Co Is Addressing Them
-Reuters
Reuters · 2d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of GSK. Analyze the recent business situations of GSK through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average GSK stock price target is 48.21 with a high estimate of 53.50 and a low estimate of 40.13.
EPS
Institutional Holdings
Institutions: 1.12K
Institutional Holdings: 349.45M
% Owned: 13.89%
Shares Outstanding: 2.52B
TypeInstitutionsShares
Increased
267
18.99M
New
93
10.60M
Decreased
254
23.17M
Sold Out
63
1.96M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
-0.45%
Pharmaceuticals & Medical Research
-1.02%
Key Executives
Non-Executive Chairman/Independent Director
Jonathan Symonds
Chief Executive Officer/Executive Director
Emma Walmsley
Chief Financial Officer/Executive Director
Iain Mackay
Corporate Executive
Roger Connor
Corporate Executive
Brian McNamara
Corporate Executive
Luke Miels
Corporate Executive
Regis Simard
Corporate Executive
Phil Thomson
Corporate Executive
Deborah Waterhouse
Senior Vice President/General Counsel
James Ford
Senior Vice President/Director of Human Resources
Diana Conrad
Senior Vice President
Nick Hirons
Senior Vice President
Sally Jackson
Chief Technology Officer
Karenann Terrell
Chief Scientific Officer/Executive Director
Hal Barron
Other
David Redfern
Secretary
Victoria Whyte
Non-Executive Independent Director
Charles Bancroft
Non-Executive Independent Director
Marvinder Banga
Non-Executive Independent Director
Anne Beal
Non-Executive Independent Director
Vivienne Cox
Non-Executive Independent Director
Lynn Elsenhans
Non-Executive Independent Director
Laurie Glimcher
Non-Executive Independent Director
Jesse Goodman
Non-Executive Independent Director
Judy Lewent
Non-Executive Independent Director
Urs Rohner
Declaration Date
Dividend Per Share
Ex-Div Date
07/30/2021
Dividend USD 0.5225848
08/19/2021
05/04/2021
Dividend USD 0.5187034
05/20/2021
--
Dividend USD 0.6291689
02/18/2021
--
Dividend USD 0.5091635
11/12/2020
07/29/2020
Dividend USD 0.4854219
08/13/2020
04/29/2020
Dividend USD 0.4664139
05/14/2020
02/05/2020
Dividend USD 0.5594826
02/20/2020
--
Dividend USD 0.4923352
11/14/2019
--
Dividend USD 0.4583283
08/08/2019
--
Dividend USD 0.465536
05/16/2019
02/07/2019
Dividend USD 0.594243
02/21/2019
11/01/2018
Dividend USD 0.479
11/15/2018
07/25/2018
Dividend USD 0.491
08/09/2018
04/26/2018
Dividend USD 0.525
05/10/2018
02/07/2018
Dividend USD 0.647
02/22/2018
10/25/2017
Dividend USD 0.509
11/09/2017
07/26/2017
Dividend USD 0.496
08/09/2017
07/11/2017
Dividend USD 0.485
05/10/2017
04/11/2017
Dividend USD 0.566
02/22/2017
01/10/2017
Dividend USD 0.457
11/02/2016
  • All
  • Financials
  • Insiders
More
About GSK
GlaxoSmithKline PLC is a global healthcare company. The Company operates through two segments: Pharmaceuticals and Vaccines. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases. The Company makes a range of prescription medicines and vaccines products. The Pharmaceuticals business discovers, develops and commercializes medicines to treat a range of acute and chronic diseases. The Vaccines business provides vaccines for people of all ages from babies and adolescents to adults and older people. It has a portfolio of medicines in respiratory and HIV. Its Pharmaceuticals business includes Respiratory, HIV, Specialty products, and Classic and Established products. Its Vaccines business has a portfolio of over 40 pediatric, adolescent, adult, older people and travel vaccines.

Webull offers kinds of GlaxoSmithKline plc (ADR) stock information, including NYSE:GSK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GSK stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading GSK stock methods without spending real money on the virtual paper trading platform.